Acct Executive

























And no one is concerned about the fact the whole company is under investigation?
No Shorty, we are not. The only people who are concerned are the idiots that did not cover their short under $2 (like you). The company is printing cash, trading at 1x Sales and will be relisted on Nasdaq with a price significantly above it current level before the end of this year.
 






No Shorty, we are not. The only people who are concerned are the idiots that did not cover their short under $2 (like you). The company is printing cash, trading at 1x Sales and will be relisted on Nasdaq with a price significantly above it current level before the end of this year.

clients aren't stupid though. I'm sure they are asking all kinds of questions -- probably blocking mimedx from facilities. On the sales side, probably not the type of business you want to inherit.
 












No Shorty, we are not. The only people who are concerned are the idiots that did not cover their short under $2 (like you). The company is printing cash, trading at 1x Sales and will be relisted on Nasdaq with a price significantly above it current level before the end of this year.

That is a good thing. The company may need that cash to pay back the government.
 






I have faith, the products are great, I have seen 1st hand on 100's of applications where other products failed.

All of the following companies had issues not unlike MDMX:

Apple, FedEx, Chrysler, IBM, Priceline, Gen Mot, Delta, Starbucks, etc...

I'm not saying we are that level, but he products work, and work better than the vast majority of copycats. Ultimately, Uncle Sam will decide our fate.
 






The AEs will never beat the tenured relationships from Organogenesis. Health systems are moving to using the exclusively and blocking out the MANY allograft companies seeking to have their products in that space.